# Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)

Study · id `cardio:ct-nct01385176` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01385176](<https://clinicaltrials.gov/study/NCT01385176>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01385176

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 118 participants.

## Technical summary

Registry record NCT01385176. Randomized; double masking; primary purpose treatment. Start 2011-09-21 (actual); primary completion 2014-05 (actual). Results posted on 2020-01-06.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 118 participants (enrolled count; ClinicalTrials.gov record NCT01385176, source copy `cardio:ctgov-nct01385176-2026-10-28`, retrieved 2026-10-31)
- Started: 2011-09-21 (actual) (ClinicalTrials.gov record NCT01385176, source copy `cardio:ctgov-nct01385176-2026-10-28`, retrieved 2026-10-31)
- Primary completion: 2014-05 (actual) (ClinicalTrials.gov record NCT01385176, source copy `cardio:ctgov-nct01385176-2026-10-28`, retrieved 2026-10-31)
- Completion: 2027-06-30 (anticipated) (ClinicalTrials.gov record NCT01385176, source copy `cardio:ctgov-nct01385176-2026-10-28`, retrieved 2026-10-31)
- Results first posted: 2020-01-06 (ClinicalTrials.gov record NCT01385176, source copy `cardio:ctgov-nct01385176-2026-10-28`, retrieved 2026-10-31)
- Countries: Belgium; Czechia; France; Germany; Italy; Netherlands; Spain; United Kingdom (ClinicalTrials.gov record NCT01385176, source copy `cardio:ctgov-nct01385176-2026-10-28`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01385176-2026-10-28`, retrieved 2026-10-31)

## The registry's words

- Brief title: Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
- Acronym: NECTAR-HF
- Condition: Heart Failure
- Condition: Congestive Heart Failure
- Intervention (Device): Implant of investigational device system
- Intervention (Procedure): Titration during the randomization phase
- Intervention (Procedure): Titration after the randomization phase
- Intervention (Diagnostic test): Blood Draw
- Lead sponsor: Boston Scientific Corporation
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Boston Scientific (`cardio:boston-scientific`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial (`cardio:pubmed-25176942`)
- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Long-term vagal stimulation for heart failure: Eighteen month results from the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) trial (`cardio:pubmed-28663046`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 81960dfa4ed320520f0b86abde61b020707e6e0cd405872811e1bb36620b114b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
